Thursday April 4, 2019 0 comments
DENVER -- HeartHero, a medical device startup and creator of the ultra-portable, affordable, and user-friendly automated external defibrillator (AED), won the Innovation Challenge at the American College of Cardiology’s 68th Annual Scientific Session & Expo, ACC.19.
Co-hosted with AngelMD, the ACC.19 Innovation Challenge provided a platform for a select group of entrepreneurs and innovators to pitch their ideas for products and services in two categories: Artificial Intelligence Solutions and Digitally Enabled Medical Devices, with one winner selected in each category as the best new innovation to advance the field of cardiology.
HeartHero, created with the mission to save more lives from Sudden Cardiac Arrest (SCA), has developed a revolutionary personal AED device to make lifesaving technology available to the consumer market. “Elliot,” the purse-sized device, weighs just over one pound, operates using store-bought batteries, includes user-friendly step-by-step instructions and visual prompts, and features artificial intelligence as well as a partner smartphone app to track heart rhythms and streamline health data.
HeartHero and its life-saving ecosystem was selected from a group of four finalists as the winner of the ACC.19 Innovation Challenge. It was the second major “pitch-challenge” win for the startup, having won the AngelMD InnovatED Innovation Challenge at the 50th American College of Emergency Physicians (ACEP) Conference and Trade Show in October 2018.
“The American College of Cardiology conducts very competitive, global innovation challenge events,” said Dr. John Rumsfeld, chief innovation officer for the American College of Cardiology.
“These concepts are judged by internationally recognized experts in clinical medicine as well as digital innovation. HeartHero winning this event is nothing short of a tremendous accomplishment.
“It shows that HeartHero addresses a critical health problem, and is doing so with a truly novel medical device.”
“We were impressed by HeartHero’s innovative spirit in identifying and tackling an important public health issue,” said Ori Ben-Yehuda, MD, ACC.19 Innovation Challenge judge and executive director of the Clinical Trials Center at the Cardiovascular Research Foundation.
“Coupled with public education their highly portable defibrillator has the potential to save lives.”
According to the Sudden Cardiac Arrest Foundation, SCA is one of the leading causes of death in the U.S. affecting more than 350,000 people annually.
“It was an honor and privilege to share our goal of saving more lives at the ACC.19 Innovation Challenge,” said Gary Montague, HeartHero CEO and founder.
“AED’s have been around for 30+ years, the concept is not new. But HeartHero’s approach is truly innovative in its ability to empower individuals to manage SCA with a tool that will ultimately save lives.”